ArticleFrontiers in pharmacology2022

HAS2-Ezrin-ER axis plays a role in acquired antiestrogen resistance of ER-positive breast cancer.

Xiaodan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.